Partnerships & Mergers

This collaboration delivers crucial funding to Agenus while simultaneously securing sustained biologics manufacturing capacity within the United States.

The partnership will bring more than 230 advanced medical systems to 19 public hospitals throughout the country.

The partnership enables Africa CDC to reinforce its central role in advancing continental priorities, including its 2023–2027 Strategic Plan and the Africa Health Security and Sovereignty (AHSS) agenda.

The ACCESS-AD project launches in January 2026 with an ambitious goal to establish a collaborative, patient-centered approach to Alzheimer’s care throughout Europe.

This partnership with Novartis creates a vital platform to increase awareness of chronic urticaria among dermatologists and other healthcare professionals.

Nimbus will leverage its specialized expertise in computational chemistry and structure-based drug design to discover a small molecule drug candidate.

The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.

Sanofi will leverage Earendil’s artificial intelligence (AI)-powered drug discovery platform to support the design and development of multiple new therapeutic assets.

Endocare plans to launch its obesity and metabolic care services in Riyadh within the coming months, building on its successful operations in Dubai and Abu Dhabi.

The upgraded laboratory streamlines sample processing from reception through advanced analysis and genetic sequencing.